2. Gene
  3. Me3 - malic enzyme 3, NADP(+)-dependent, mitochondrial Gene

Me3 - malic enzyme 3, NADP(+)-dependent, mitochondrial Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

种属: Mus musculus

同用名: 1700020C08Rik; B230207H15Rik

基因 ID: 109264 | 基因类型: protein coding

关于 Me3

功能概要

Predicted to enable NADP+ binding activity and malate dehydrogenase (decarboxylating) (NADP+) activity. Predicted to be involved in malate metabolic process and pyruvate metabolic process. Located in mitochondrion. Is expressed in several structures, including alimentary system; central nervous system; integumental system; metanephros; and sensory organ. Orthologous to human ME3 (malic enzyme 3). [provided by Alliance of Genome Resources, Apr 2022]

Me3 基因产物(1)

mRNA Protein Name
NM_181407.4 NP_852072.2 NADP-dependent malic enzyme, mitochondrial
基因本体论
  • 分子功能
  • 生物过程
  • 细胞组分
分子功能 GO 注释 逻辑证据 参考文献 来源
enables malate dehydrogenase (decarboxylating) (NADP+) activity IDA
IDA: 通过直接分析推断
25711 MGI
生物过程 GO 注释 逻辑证据 参考文献 来源
involved in pyruvate metabolic process IDA
IDA: 通过直接分析推断
25711 MGI
细胞组分 GO 注释 逻辑证据 参考文献 来源
is active in mitochondrial matrix IDA
IDA: 通过直接分析推断
25711 MGI
EXP：通过实验结果推断 IDA：通过直接分析推断 IPI：通过物理相互作用推断 IMP：通过突变表型推断 IGI：通过遗传相互作用推断 IEP：通过表达模式推断
蛋白主名 其他名称

NADP-dependent malic enzyme, mitochondrial

NADP-ME

相关产品

Clinical Phase
生物活性分子 (1)
目录号 产品名 作用方式
纯度 Phase
HY-159834 Progerinin Inhibitor 99.74% Phase 2
Pre-clinical Phase
生物活性分子 (67)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-15648B GSK-J4 99.45% 否
HY-100421 CPI-455 Inhibitor 98.95% 否
HY-101117 EED226 Inhibitor 99.56% 否
HY-15648F GSK-J4 hydrochloride Inhibitor 99.01% 否
HY-12583 A-366 Inhibitor 98.13% 否
HY-120400 KDM5-C70 Inhibitor 98.82% 否
HY-150190 F5446 99.73% 否
HY-15648 GSK-J1 Inhibitor 99.94% 否
HY-16705 BRD4770 Inhibitor 99.69% 否
HY-N7404 Nε,Nε,Nε-Trimethyllysine chloride 99.14% 否
HY-100014 KDM5A-IN-1 Inhibitor 99.64% 否
HY-119344 MS37452 Inhibitor 99.81% 否
HY-148458 EZH2-IN-14 Inhibitor 99.02% 否
HY-110154 NSC636819 98.90% 否
HY-153191 EZH2-IN-15 Inhibitor 99.18% 否
HY-125292 NV03 Antagonist 99.77% 否
HY-100421A CPI-455 hydrochloride Inhibitor 99.95% 否
HY-138691A JQKD82 trihydrochloride Inhibitor 99.89% 否
HY-N7404S Nε,Nε,Nε-Trimethyllysine-d9 chloride 95.0% 否
HY-125837A MS31 trihydrochloride Inhibitor 98.0% 否
HY-132896 KDM4-IN-3 Inhibitor 99.36% 否
HY-150249 GSK3735967 Inhibitor 99.34% 否
HY-15648A GSK-J2 Control 99.75% 否
HY-100764 YUKA1 Inhibitor 99.15% 否
HY-158432 GT-653 Degrader 99.84% 否
HY-66026 Fmoc-Lys(Me)3-OH Chloride 98.60% 否
HY-P2254 H3K27(Me3) (15-34) 96.97% 否
HY-126327A UNC4976 TFA Antagonist 98.0% 否
HY-15648D GSK-J1 lithium salt Inhibitor 98.33% 否
HY-126327 UNC4976 Antagonist / 否
HY-P2255 H3K4(Me) (1-20) 99.82% 否
HY-125837 MS31 Inhibitor / 否
HY-120766 NCDM-32B Inhibitor 97.0% 否
HY-P10463A ssK36 TFA Inhibitor 99.34% 否
HY-P2257 H3K4(Me3) (1-20) 98.69% 否
HY-W051391 1,4,7-Trimethyl-1,4,7-triazonane 98.50% 否
HY-W100209 5Me3F4AP Inhibitor 99.55% 否
HY-169061 WQQ-345 / 否
HY-122595 EZH2-IN-1 Inhibitor / 否
HY-122640 NPD13668 Inhibitor / 否
HY-138691 JQKD82 Inhibitor / 否
HY-143616 EZH2-IN-7 Inhibitor / 否
HY-150619 KDM4-IN-4 Inhibitor / 否
HY-154599 5-Me-3’-dU-2’-phosphoramidite / 否
HY-156292 IHMT-EZH2-426 Inhibitor / 否
HY-15648G GSK-J1 sodium Inhibitor / 否
HY-15648I GSK-J2 sodium Inhibitor / 否
HY-162601 D-01 Inhibitor / 否
HY-168131 PROTAC EZH2 Degrader-3 / 否
HY-169375 RSL3-4-Me Control / 否
HY-174397 EED-IN-3 Inhibitor / 否
HY-178694 DC-PRC2in-01 Inhibitor / 否
HY-179446 HP1-IN-2 Inhibitor / 否
HY-179499 PROTAC EZH2 Degrader-9 / 否
HY-181089 CBX2-IN-1 Inhibitor / 否
HY-181413 PROTAC EZH2 Degrader-44 / 否
HY-181914 UNC7242 Antagonist / 否
HY-P10111A Histone H3K9me3 (1-15) TFA / 否
HY-P2252 H3K27(Me) (15-34) / 否
HY-P2253 H3K27(Me2) (15-34) / 否
HY-RS08272 ME3 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-106258 Atilmotin Agonist / 否
HY-138691B JQKD82 dihydrochloride Inhibitor / 否
HY-169919 HDM-IN-1 Inhibitor / 否
HY-P10463 ssK36 Inhibitor / 否
HY-RS19564 Me3 Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS26060 Me3 Rat Pre-designed siRNA Set A Pre-designed Set / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens Me3 NCBI NCBI:10873
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z